Information Library
Results for: Faster product development - North and Central America
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India
Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.
-
QUINTILES TO BE KEY PARTICIPANT AT SOCIETY FOR CLINICAL DATA MANAGEMENT ANNUAL CONFERENCE
Press Release — October 12, 2010 - Quintiles’ Paula Brown Stafford, President, Clinical Development will open the conference with a keynote speech on the evolution from data management to information management.
-
QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL
Press Release — October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.
-
QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE
Press Release — July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program.
-
Malaysia Prime Site
Video — July 2, 2010
Adam Chasse, Sr. Director, Access to Patients explains the importance of Prime Sites and the impact of our clinical research partnership with the University of Malaya Medical Centre in Malaysia. -
THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT
Press Release — June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.
-
THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS
Press Release — June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.
-
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
Press Release — June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT
Press Release — May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program
-
QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY
Press Release — February 17, 2010 - Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.
